Comparative cost-effectiveness of neoadjuvant chemotherapy regimens for muscle-invasive bladder cancer: Results according to VESPER data.
Cancer
; 128(24): 4194-4202, 2022 12 15.
Article
in En
| MEDLINE
| ID: mdl-36251574
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Urinary Bladder Neoplasms
Type of study:
Clinical_trials
/
Health_economic_evaluation
/
Prognostic_studies
Aspects:
Patient_preference
Limits:
Humans
Language:
En
Journal:
Cancer
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: